Skip to main content
BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
9.83
+0.16 (1.65%)
Nov 20, 2024, 4:00 PM EST - Market closed

BrainsWay Revenue

BrainsWay had revenue of $10.50M in the quarter ending September 30, 2024, with 26.50% growth. This brings the company's revenue in the last twelve months to $38.63M, up 34.19% year-over-year. In the year 2023, BrainsWay had annual revenue of $31.79M with 16.96% growth.

Revenue (ttm)
$38.63M
Revenue Growth
+34.19%
P/S Ratio
n/a
Revenue / Employee
$288,291
Employees
134
Market Cap
184.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202331.79M4.61M16.96%
Dec 31, 202227.18M-2.48M-8.36%
Dec 31, 202129.66M7.60M34.46%
Dec 31, 202022.06M-1.04M-4.52%
Dec 31, 201923.10M6.70M40.89%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 137.74M
Biodesix 65.56M
2seventy bio 45.62M
Nanobiotix 45.22M
Cellectis 36.04M
Senseonics Holdings 22.21M
Caribou Biosciences 11.48M
Revenue Rankings

BWAY News

More News